Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001710166-17-000001
Filing Date
2017-10-04
Accepted
2017-10-04 15:33:43
Documents
1
Effectiveness Date
2017-10-04
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 4863
  Complete submission text file 0001710166-17-000001.txt   5935
Mailing Address 20600 CHAGRIN BOULEVARD SUITE 210 CLEVELAND OH 44122
Business Address 20600 CHAGRIN BOULEVARD SUITE 210 CLEVELAND OH 44122 216-455-3200
Koutif Therapeutics, LLC (Filer) CIK: 0001710166 (see all company filings)

EIN.: 821873076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-296006 | Film No.: 171121487